目前认为 , 各种脑损伤 ( 脑缺氧、脑外伤 ) 的继发性损伤或称二次脑损伤 (secondary injury) 因素是造成脑损害发生、发展的重要原因。
这些因素涉及：脑缺氧、钙离子超载、氧自由基堆积、炎性因子的刺激等。其中炎症应答 (inflammatory response) 是脑损伤病理生理过程中的一个重要组成环节，半胱氨酰白三烯 (cysteinyl LTs) 包括LTC4, LTD4 和 LTE4 是一类重要的炎症反应介质 , 是花生四烯酸 5-脂氧合酶 (5-lipoxygenase,5-LOX) 的代谢产物。 CysLTs 通过激活半胱氨酰白三烯受体 ( 包括 CysLT1 和 CysLT2 受体 ), 参与多种炎症病理过程 , 介导平滑肌痉挛 (smooth muscle constriction) 、微血管渗漏 (vascular leak) 等。近年研究证明 , CysLTs 除在哮喘、过敏性鼻炎等炎症性疾病发病过程中起重要作用外 , 也参与脑卒中、脑外伤、脑肿瘤、癫痫等中枢神经系统疾病的病理生理过程。脑缺血后CysLTs 释放增加 , 5-LOX 抑制剂能减少 CysLTs 的产生，从而保护脑缺血性损伤。
相关产品如下：
| 产品名称 | 货号 | 规格 | 供应商 |
| A-803467 | 10012588 | 5/10/50/100mg | Cayman |
| N-Ac-Tyr-Val-Ala-Asp-CMK | 10014 | 1/5/10/25mg | Cayman |
| AFMK | 10005254 | 1/5/10/50mg | Cayman |
| Agomelatine | 13203 | 5/10/50/100mg | Cayman |
| AL 34662 | 10011546 | 1/5/10/50mg | Cayman |
| AM251 | 71670 | 5/10/50/100mg | Cayman |
| AM404 | 90060 | 5/10/50/100mg | Cayman |
| AM630 | 10006974 | 5/10/50/100mg | Cayman |
| AM1172 | 10005223 | 1/5/10g/50mg | Cayman |
| AM1241 | 10010118 | 1/5/10/25mg | Cayman |
| (R)-AM1241 | 10491 | 1/5/10/25mg | Cayman |
| (S)-AM1241 | 10490 | 1/5/10/25mg | Cayman |
| AM3102 | 13452 | 5/10/25/50mg | Cayman |
| N-Arachidonoyl-L-Alanine | 90065 | 5/10/25/50mg | Cayman |
| Arachidonoyl Amide | 10007295 | 5/10/25/50mg | Cayman |
| AMC Arachidonoyl Amide | 10005098 | 5/10/25/50mg | Cayman |
| 7-Aminoclonazepam-d4* | 10010670 | 1/5/10mg | Cayman |
| β-Amyloid(1-8) Peptide | 10241 | 1ea | Cayman |
| β-Amyloid(1-8, A2V) Peptide | 10229 | 1ea | Cayman |
| Apelin-13 | 13523 | 1/5/10/25mg | Cayman |
| N-(3-hydroxyphenyl)-Arachidonoyl Amide | 10007704 | 5/10/50/100mg | Cayman |
| 产品名称 | 货号 | 规格 | 供应商 |
| N-Arachidonoyl-γ-Aminobutyric Acid | 90067 | 5/10/25/50mg | Cayman |
| N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid | 10158 | 1/5/10/50 mg | Cayman |
| Arachidonoyl 2’-Chloroethylamide | 91054 | 5/10/50/100mg | Cayman |
| Arachidonoyl Cyclopropylamide | 91053 | 5/10/50/100mg | Cayman |
| Arachidonoyl-N,N-dimethyl amide | 10007293 | 5/10/50/100mg | Cayman |
| N-Arachidonoyl Dopamine | 90057 | 5/10/50/100mg | Cayman |
| Arachidonoyl Ethanolamide | 90050 | 5/10/50/100mg | Cayman |
| oxy-Arachidonoyl Ethanolamide | 10008642 | 5/10/25/50mg | Cayman |
| Arachidonoyl Ethanolamide Phosphate | 10180 | 250ug/500ug, 1mg/5mg | Cayman |
| O-Arachidonoyl Ethanolamine | 91050 | 1/5/10/25mg | Cayman |
| Arachidonoyl 2’-Fluoroethy-lamide | 90054 | 5/10/50/100mg | Cayman |
(±)-2-Methyl Arachidonoyl-2’-Fluoroethylamide | 90055 | 1/5/10/25mg | Cayman |
| Methyl Arachidonyl Fluorop-hosphonate | 70660 | 1/5/10/25mg | Cayman |
| Arachidonoyl-1-thio-Glycerol | 10007904 | 1/5/10/25mg | Cayman |
| 1-Arachidonoyl Glycerol | 62150 | 1/5/10/25mg | Cayman |
| 1-Arachidonoyl Glycerol-d5 | 362152 | 100ug/500ug /1mg/5mg | Cayman |
| 2-Arachidonoyl Glycerol | 62160 | 1/5/10/25mg | Cayman |
| 2-Arachidonoyl Glycerol-d5 | 362162 | 50ug/100ug /500ug/1mg | Cayman |
| 2-Arachidonoyl Glycerol-d8 | 362160 | 25/50/100/500ug | Cayman |
| O-Arachidonoyl Glycidol | 10010547 | 5/10/50/100mg | Cayman |
| Arachidonoyl Glycine | 90051 | 5/10/50/100mg | Cayman |
| Arachidonoyl-N-methyl amide | 10007294 | 5/10/50/100mg | Cayman |
| Arachidonoyl m-Nitroaniline | 90059 | 5/10/25/50mg | Cayman |
| Arachidonoyl Serinol | 62170 | 5/10/50/100mg | Cayman |
更多产品详情，请联系Cayman一级代理商-3868la银河总站生物
全国服务热线: 4006-800-892 邮箱: market@neobioscience.com
深圳: 0755-26755892 北京: 010-88594029 上海: 021-34613729
广州：020-87615159 香港: 852-69410778
代理品牌网站: www.neobioscience.com
自主品牌网站: www.neobioscience.net